US Patent Issued to Universitatsmedizin Der Johannes Gutenberg-Univeristat Mainz on April 21 for "Modified NK-92 cells, and therapeutic and diagnostic uses thereof" (German Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,608, issued on April 21, was assigned to Universitatsmedizin Der Johannes Gutenberg-Univeristat Mainz (Mainz, Germany).

"Modified NK-92 cells, and therapeutic and diagnostic uses thereof" was invented by Udo Hartwig (Nackenheim, Germany), Jan Wernersbach (Mainz, Germany) and Catherine Woelfel (Mainz, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Modified natural killer 92 (NK-92) cells and their use in cancer therapy, in particular for the prevention or treatment of solid tumours such as sarcomas, carcinomas, melanoma and lymphoma, and non-solid tumours such as leukaemia and related disorders. Embodiments of the invention further relate to...